Search Bar & Filters
Found 4 Actively Recruiting clinical trials
Actively Recruiting
This research aims to compare two approaches for treating previously untreated amblyopia in children aged 3 to under 13 years. It evaluates whether using glasses and patching at the same time leads to similar improvements in vision as first using glasses alone, followed by patching only if needed. The trial focuses on children with amblyopia caused by differences in eye alignment or prescription errors. Children will be assigned randomly to one of two treatment groups one group will wear glasses full-time and add patching for 2 hours daily only if there is no improvement after glasses alone the other group will wear glasses and patch the weaker eye for 2 hours daily at the same time from the start. Vision tests will be done at baseline and follow-up visits every 8 weeks for up to 56 weeks. Participants will have their distance visual acuity measured with trial frames before and after getting their glasses to confirm eligibility. During the study, vision will be monitored to classify improvement or stability, guiding whether patching is needed in the sequential group. Outcomes include changes in vision clarity after 56 weeks and quality-of-life assessments. Regular visits help track progress and safety until study completion.
Actively Recruiting
Researchers are evaluating treatments for amblyopia in children aged 4 to 7 years. The study compares watching dichoptic movies or shows using the Luminopia virtual reality headset for 1 hour a day, 6 days a week, against patching the fellow eye for 2 hours a day, 7 days a week. The goal is to see if the dichoptic treatment is not worse than patching in improving distance visual acuity in the amblyopic eye over 26 weeks. Participants are randomly assigned to one of two groups the Luminopia group, who watch dichoptic content through a headset daily, or the patching group, who wear an eye patch for specified times. After 26 weeks, if participants in the patching group do not show sufficient improvement, they are offered the Luminopia therapy with follow-up visits at weeks 39 and 52. Those who do not qualify for this extension end the study after 26 weeks. During the study, participants undergo clinical assessments at 13 and 26 weeks post-randomization to measure changes in vision. Follow-up visits are scheduled for participants who switch to Luminopia after patching if needed. Researchers monitor adherence to treatment, visual acuity changes, and any safety concerns throughout the trial, which lasts up to 52 weeks for some participants.
Actively Recruiting
This research is evaluating dichoptic treatments for children aged 8 to 12 years with amblyopia, a vision condition. Participants will be randomly assigned to one of three groups wearing the Luminopia headset to watch dichoptic movies, using the Vivid Vision headset to play dichoptic games, or continuing with optical correction alone if needed. The study aims to compare these approaches to improve visual acuity in the amblyopic eye. Participants assigned to the Luminopia group will watch dichoptic movies or shows for one hour daily, six days per week, while using their prescribed optical correction if needed. The Vivid Vision group will play dichoptic games using a virtual reality headset for approximately 25 minutes daily, six days per week, also with optical correction if required. The third group will continue full-time optical correction alone. At 18 weeks, those initially on optical correction alone who show significant vision difference may be offered a chance to try either dichoptic treatment, with follow-up visits extending to 36 weeks. Throughout the study, participants will have clinical assessments at 9 and 18 weeks after starting treatment. Those switching to dichoptic therapy after 18 weeks will have additional visits at 27 and 36 weeks. Researchers will measure changes in visual acuity of the amblyopic eye and assess quality of life through questionnaires. The study includes monitoring adherence to treatments and continues for up to 36 weeks for some participants, with safety and effectiveness evaluated during follow-up visits.
Actively Recruiting
Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.